Neuronetics (NRC) Ratios
3 Followers
Neuronetics Ratios
DE:NRC's free cash flow for Q3 2026 was $-408.00K. For the 2026 fiscal year, DE:NRC's free cash flow was decreased by $-470.00K and operating cash flow was $62.00K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.02 | 1.86 | 4.73 | 2.98 | 7.34 |
| Quick Ratio | 1.87 | 1.72 | 4.33 | 2.71 | 6.93 |
| Cash Ratio | 1.12 | 0.62 | 3.01 | 2.12 | 6.00 |
| Solvency Ratio | -0.31 | -0.38 | -0.35 | -0.59 | -0.54 |
| Operating Cash Flow Ratio | -0.67 | -0.99 | -1.62 | -0.93 | -1.78 |
| Short-Term Operating Cash Flow Coverage | -3.66 | 0.00 | 0.00 | -2.34 | 0.00 |
| Net Current Asset Value | $ -53.76M | $ -50.98M | $ 12.15M | $ 38.95M | $ 59.28M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.64 | 0.59 | 0.54 | 0.34 | 0.28 |
| Debt-to-Equity Ratio | 4.04 | 2.98 | 1.83 | 0.70 | 0.46 |
| Debt-to-Capital Ratio | 0.80 | 0.75 | 0.65 | 0.41 | 0.32 |
| Long-Term Debt-to-Capital Ratio | 0.75 | 0.67 | 0.63 | 0.29 | 0.29 |
| Financial Leverage Ratio | 6.33 | 5.09 | 3.39 | 2.05 | 1.66 |
| Debt Service Coverage Ratio | -1.94 | -4.72 | -4.19 | -1.91 | -8.13 |
| Interest Coverage Ratio | -3.74 | -4.74 | -5.63 | -9.75 | -8.35 |
| Debt to Market Cap | 0.78 | 1.08 | 0.71 | 0.19 | 0.31 |
| Interest Debt Per Share | 1.50 | 2.83 | 2.37 | 1.61 | 1.68 |
| Net Debt to EBITDA | -2.07 | -1.84 | -0.12 | 0.96 | 2.04 |
| Profitability Margins | |||||
| Gross Profit Margin | 48.48% | 72.32% | 72.47% | 76.26% | 78.93% |
| EBIT Margin | -20.50% | -48.66% | -34.71% | -51.54% | -50.39% |
| EBITDA Margin | -18.18% | -45.89% | -31.90% | -49.01% | -48.48% |
| Operating Profit Margin | -21.08% | -46.15% | -42.82% | -53.85% | -49.83% |
| Pretax Profit Margin | -26.15% | -58.41% | -42.31% | -57.06% | -56.36% |
| Net Profit Margin | -26.15% | -58.36% | -42.31% | -56.99% | -56.39% |
| Continuous Operations Profit Margin | -26.15% | -58.39% | -42.28% | -57.06% | -56.36% |
| Net Income Per EBT | 100.00% | 99.92% | 100.00% | 99.87% | 100.06% |
| EBT Per EBIT | 124.06% | 126.55% | 98.81% | 105.97% | 113.10% |
| Return on Assets (ROA) | -27.55% | -31.02% | -26.06% | -31.79% | -22.09% |
| Return on Equity (ROE) | -174.27% | -157.76% | -88.30% | -65.12% | -36.62% |
| Return on Capital Employed (ROCE) | -28.31% | -31.52% | -31.82% | -41.96% | -21.96% |
| Return on Invested Capital (ROIC) | -26.96% | -30.20% | -31.52% | -35.96% | -21.84% |
| Return on Tangible Assets | -39.08% | -42.57% | -26.06% | -31.79% | -22.09% |
| Earnings Yield | -42.85% | -85.55% | -36.32% | -20.11% | -27.45% |
| Efficiency Ratios | |||||
| Receivables Turnover | 8.83 | 3.08 | 4.00 | 4.72 | 7.11 |
| Payables Turnover | 7.16 | 1.87 | 4.13 | 6.36 | 2.71 |
| Inventory Turnover | 17.76 | 4.88 | 2.43 | 1.74 | 1.78 |
| Fixed Asset Turnover | 5.32 | 2.25 | 14.92 | 12.26 | 10.84 |
| Asset Turnover | 1.05 | 0.53 | 0.62 | 0.56 | 0.39 |
| Working Capital Turnover Ratio | 5.15 | 1.49 | 1.02 | 0.79 | 0.73 |
| Cash Conversion Cycle | 10.88 | -1.89 | 153.34 | 229.80 | 122.25 |
| Days of Sales Outstanding | 41.34 | 118.36 | 91.26 | 77.37 | 51.34 |
| Days of Inventory Outstanding | 20.55 | 74.80 | 150.38 | 209.79 | 205.57 |
| Days of Payables Outstanding | 51.01 | 195.05 | 88.30 | 57.36 | 134.66 |
| Operating Cycle | 61.89 | 193.16 | 241.64 | 287.15 | 256.91 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.31 | -0.98 | -1.12 | -1.14 | -1.10 |
| Free Cash Flow Per Share | -0.32 | -1.02 | -1.20 | -1.26 | -1.19 |
| Dividend Paid and CapEx Coverage Ratio | -25.44 | -21.14 | -13.52 | -9.40 | -11.89 |
| Capital Expenditure Coverage Ratio | -25.44 | -21.14 | -13.52 | -9.40 | -11.89 |
| Operating Cash Flow Coverage Ratio | -0.23 | -0.38 | -0.51 | -0.77 | -0.71 |
| Operating Cash Flow to Sales Ratio | -0.14 | -0.41 | -0.45 | -0.47 | -0.51 |
| Free Cash Flow Yield | -23.27% | -63.54% | -41.40% | -18.40% | -26.70% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.34 | -1.17 | -2.75 | -4.97 | -3.64 |
| Price-to-Sales (P/S) Ratio | 0.61 | 0.68 | 1.16 | 2.83 | 2.05 |
| Price-to-Book (P/B) Ratio | 4.07 | 1.84 | 2.43 | 3.24 | 1.33 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -4.30 | -1.57 | -2.42 | -5.43 | -3.75 |
| Price-to-Operating Cash Flow Ratio | -4.47 | -1.65 | -2.59 | -6.01 | -4.06 |
| Price-to-Earnings Growth (PEG) Ratio | 0.04 | -0.04 | 0.12 | -0.38 | 0.22 |
| Enterprise Value Multiple | -5.43 | -3.32 | -3.77 | -4.83 | -2.20 |
| Enterprise Value | 147.18M | 114.26M | 85.91M | 154.21M | 59.04M |
| EV to EBITDA | -5.43 | -3.32 | -3.77 | -4.83 | -2.20 |
| EV to Sales | 0.99 | 1.53 | 1.20 | 2.36 | 1.07 |
| EV to Free Cash Flow | -6.95 | -3.52 | -2.50 | -4.53 | -1.95 |
| EV to Operating Cash Flow | -7.22 | -3.69 | -2.68 | -5.02 | -2.11 |
| Tangible Book Value Per Share | -0.24 | -0.20 | 1.19 | 2.12 | 3.34 |
| Shareholders’ Equity Per Share | 0.34 | 0.87 | 1.19 | 2.12 | 3.34 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 2.26 | 2.36 | 2.49 | 2.42 | 2.17 |
| Net Income Per Share | -0.59 | -1.38 | -1.05 | -1.38 | -1.22 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.28 | 1.20 | 1.22 | 1.11 | 1.12 |
| Research & Development to Revenue | 0.04 | 0.17 | 0.13 | 0.14 | 0.14 |
| SG&A to Revenue | 0.65 | 1.01 | 0.36 | 0.39 | 0.46 |
| Stock-Based Compensation to Revenue | 0.05 | 0.07 | 0.10 | 0.13 | 0.14 |
| Income Quality | 0.52 | 0.71 | 1.06 | 0.83 | 0.90 |
Currency in USD
